Skip to main content
Top

Drugs

Issue 13/2015

Content (10 Articles)

Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions

  • Leading Article

Mark N. Polizzotto, Grace Chen, Randall L. Tressler, Catherine Godfrey

Diabetic Macular Edema: Options for Adjunct Therapy

  • Leading Article

Pilar Calvo, Beatriz Abadia, Antonio Ferreras, Oscar Ruiz-Moreno, Guayente Verdes, Luis E. Pablo

A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis

  • Therapy in Practice

Xavier Liem, Fred Saad, Guila Delouya

Use of Integrase Inhibitors in HIV-Infected Children and Adolescents

  • Review Article

Walter Dehority, Jacobo Abadi, Andrew Wiznia, Rolando M. Viani

Pharmacotherapy for Status Epilepticus

  • Open Access
  • Review Article

Eugen Trinka, Julia Höfler, Markus Leitinger, Francesco Brigo

Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes

  • Adis Drug Evaluation

Sarah L. Greig, Lesley J. Scott

Empagliflozin/Linagliptin: A Review in Type 2 Diabetes

  • Adis Drug Evaluation

Esther S. Kim, Emma D. Deeks

Sonidegib: First Global Approval

  • AdisInsight Report

Celeste B. Burness

Evolocumab: First Global Approval

  • AdisInsight Report

Anthony Markham

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images